Throughout my academic career, I have significantly contributed to the field of basic science and
neuromuscular clinical science, leaving a remarkable impact through an extensive body of work. As the lead
writer for an ultimately funded R01 grant, I've employed my expertise and strategic insights to secure crucial
funding for important research projects. My scholarly pursuits have also led to several peer-reviewed
papers, further strengthening the knowledge base in these complex scientific disciplines. Beyond the realm
of publishing, I have been an active participant in national conferences, contributing to the scholarly
dialogue through delivering insightful talks and engaging poster presentations. Today, as a dedicated
professional at Michigan Medicine, I am committed to driving healthcare innovations. I'm tirelessly striving to
establish cutting-edge programs that will elevate our level of care. Among these initiatives are a dedicated
pediatric comprehensive nerve clinic and a focus on pediatric dysautonomic disorders, both aimed at better
addressing the needs of our youngest patients. Moreover, I am deeply involved in the development of next generation treatments for Facioscapulohumeral Muscular Dystrophy (FSHD), further exemplifying my
dedication to advancing medical science and improving patient outcomes.

Passionate about translational research, I am devoted to establishing our multidisciplinary pediatric
neuropathy clinic. This initiative aims to meet national clinical trial outcome standards, thereby positioning
Michigan as a vital trial site, while addressing a significant gap in the neuromuscular field by developing
pediatric-specific outcomes. I am actively collaborating with our basic scientists specializing in nerve
regeneration, inflammation, and kinesiology, aiming to apply their expertise to pediatric-focused measures.
This synergy enhances our understanding of the differences between pediatric and adult neuromuscular
conditions, thus improving patient outcomes. Additionally, I am eager to work with rheumatology and
genetics professionals to broaden our knowledge and refine treatment strategies for pediatric hereditary and
acquired neuropathies, thereby improving care quality and advancing our understanding of these complex
conditions.